Beyfortus 100 mg

BEYFORTUS 100 MG is a solution containing nirsevimab, used for respiratory syncytial virus (RSV) prevention. This intramuscular solution is manufactured by Sanofi Pasteur Limited in Canada.

BEYFORTUS 100 MG is primarily used for the prevention of RSV infections. RSV is a common respiratory virus that can cause severe illness, particularly in infants and young children. Nirsevimab, the active ingredient in BEYFORTUS, is designed to provide protection against RSV by targeting the virus directly. This medication is often recommended for use during the RSV season to help reduce the risk of infection and its associated complications.

The effects of BEYFORTUS 100 MG are focused on preventing RSV infections. By targeting the virus, nirsevimab helps to reduce the likelihood of developing symptoms associated with RSV, such as coughing, wheezing, and difficulty breathing. This can help to minimize the need for medical intervention and hospitalizations related to RSV.

BEYFORTUS 100 MG should be administered by a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions you have before receiving this medication. Always follow the storage and handling instructions provided with the product to ensure its effectiveness and safety.

BEYFORTUS 100 MG may interact with other medications, so it is important to inform your healthcare provider about all the medications you are currently taking. This includes prescription drugs, over-the-counter medications, and any herbal supplements. Additionally, alcohol and certain foods may affect the way this medication works, so it is best to discuss any dietary considerations with your healthcare provider.